Winfield Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-123
Closed -$5K 516
2017
Q4
$5K Hold
123
﹤0.01% 526
2017
Q3
$4K Sell
123
-14
-10% -$482 ﹤0.01% 531
2017
Q2
$5K Sell
137
-21
-13% -$709 ﹤0.01% 531
2017
Q1
$5K Buy
+158
New +$4.87K ﹤0.01% 471

Other funds holding QGEN

Winfield Associates's QGEN Position: Q1 2018 in Review

Winfield Associates sold out of Qiagen (QGEN) in Q1 2018, closing a stake of 123 shares — an estimated $5K sold.

Winfield Associates first reported a position in QGEN in Q1 2017 and held it in 4 quarters. The position peaked at $5K in Q4 2017. 230 funds tracked by Wall St. Rank hold QGEN as of Q1 2018.

  • Winfield Associates reported no remaining Qiagen position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 123 Qiagen shares in Q1 2018, an estimated $5K.
  • Winfield Associates first reported a position in Qiagen in Q1 2017 and held it in 4 quarters.
  • Winfield Associates's Qiagen position peaked at $5K in Q4 2017.
  • 230 funds tracked by Wall St. Rank held Qiagen as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.